U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H15NO5.ClH
Molecular Weight 313.734
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FOLESCUTOL HYDROCHLORIDE

SMILES

Cl.OC1=C(O)C=C2C(CN3CCOCC3)=CC(=O)OC2=C1

InChI

InChIKey=INYLJXSQMJVYLG-UHFFFAOYSA-N
InChI=1S/C14H15NO5.ClH/c16-11-6-10-9(8-15-1-3-19-4-2-15)5-14(18)20-13(10)7-12(11)17;/h5-7,16-17H,1-4,8H2;1H

HIDE SMILES / InChI
Molecular Formula C14H15NO5
Molecular Weight 277.2726
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Folescutol has been studied in phlebology. It was shown, that the drug could prevent the edema by revascularization.

Approval Year

Unknown
139594
PubMed

PubMed

TitleDatePubMed
[Clinical trial of Folescutol in phlebology].
1972 Jun
Substance Class Chemical
Created
by admin
on Sat Dec 16 09:59:58 UTC 2023
Edited
by admin
on Sat Dec 16 09:59:58 UTC 2023
Record UNII
P2WXU7R49P
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FOLESCUTOL HYDROCHLORIDE
MI  
Common Name English
2H-1-BENZOPYRAN-2-ONE, 6,7-DIHYDROXY-4-(4-MORPHOLINYLMETHYL)-, HYDROCHLORIDE (1:1)
Systematic Name English
LD-2988
Code English
COVALAN
Brand Name English
4-MORPHOLINOMETHYLESCULETOL HYDROCHLORIDE
Common Name English
FOLESCUTOL HYDROCHLORIDE [MI]
Common Name English
Code System Code Type Description
PUBCHEM
56843193
Created by admin on Sat Dec 16 09:59:59 UTC 2023 , Edited by admin on Sat Dec 16 09:59:59 UTC 2023
PRIMARY
MERCK INDEX
m193
Created by admin on Sat Dec 16 09:59:59 UTC 2023 , Edited by admin on Sat Dec 16 09:59:59 UTC 2023
PRIMARY Merck Index
EPA CompTox
DTXSID00189566
Created by admin on Sat Dec 16 09:59:59 UTC 2023 , Edited by admin on Sat Dec 16 09:59:59 UTC 2023
PRIMARY
CAS
36002-19-4
Created by admin on Sat Dec 16 09:59:59 UTC 2023 , Edited by admin on Sat Dec 16 09:59:59 UTC 2023
PRIMARY
FDA UNII
P2WXU7R49P
Created by admin on Sat Dec 16 09:59:59 UTC 2023 , Edited by admin on Sat Dec 16 09:59:59 UTC 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966